Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.7180
+0.0239 (3.44%)
Feb 10, 2026, 4:00 PM EST - Market closed

Oragenics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3514125241
Market Cap Growth
-19.41%-68.80%16.96%-76.19%25.99%78.59%
Enterprise Value
-831112640
Last Close Price
0.7211.08168.81189.20802.88808.28
PS Ratio
--383.9393.97596.78-
PB Ratio
0.30-21.294.560.951.962.45
P/TBV Ratio
0.31-9.181.082.184.26
EV/Sales Ratio
--286.836.33294.77-
Debt / Equity Ratio
0.04-1.550.100.050.030.05
Asset Turnover
--0.000.010.00-
Quick Ratio
3.970.511.947.1718.8713.14
Current Ratio
4.420.872.158.9519.1713.40
Return on Equity (ROE)
-168.95%-714.95%-255.36%-72.35%-72.52%-155.13%
Return on Assets (ROA)
-71.33%-204.98%-132.48%-41.93%-42.03%-86.66%
Return on Capital Employed (ROCE)
-103.90%4983.30%-659.80%-109.60%-58.90%-153.70%
Earnings Yield
-356.08%-234.31%-142.89%-115.61%-30.27%-64.15%
FCF Yield
-275.25%-190.62%-50.43%-124.24%-26.03%-41.14%
Buyback Yield / Dilution
-1588.05%-194.35%-11.97%-3.40%-106.24%-33.69%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q